DV
Dynavax
DVAX·NASDAQEmeryville CAFounded 1996500 employees
Small CapbiotechPublicInfectious Disease
Platform: CpG Adjuvant
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (DVAX)
Loading DVAX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rilurelsin | DVA-5594 | Phase 1/2 | 1 | SOS1 | MCL | ||
| Fixamavacamten | DVA-2301 | Phase 2 | 2 | SOS1 | AMLEwing Sarcoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)